Cardiac biomarkers in haemodialysis patients: The prognostic value of amino-terminal pro-B-type natriuretic peptide and cardiac troponin T

Nephron - Clinical Practice

Volumn 107, Issue 3, 2007, Pages

  Sommerer, Claudia ^a   Giannitsis, Evangelos ^a   Schwenger, Vedat ^a   Zeier, Martin ^a  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

Amino terminal pro B type natriuretic peptide; Cardiac biomarker; Cardiovascular mortality; Haemodialysis; Hypervolaemia; Troponin

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; TROPONIN T;

CARDIOVASCULAR DISEASE; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY DISEASE; DIABETES MELLITUS; HEART DISEASE; HEART MUSCLE ISCHEMIA; HEART VENTRICLE HYPERTROPHY; HEMODIALYSIS; HUMAN; KIDNEY FAILURE; KIDNEY FUNCTION; MORBIDITY; MORTALITY; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; SCREENING; SHORT SURVEY;

BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; HUMANS; KIDNEY FAILURE, CHRONIC; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; PROGNOSIS; RENAL DIALYSIS; RISK ASSESSMENT; RISK FACTORS; SENSITIVITY AND SPECIFICITY; TROPONIN T;

EID: 35948932544     PISSN: 16602110     EISSN: None     Source Type: Journal    
DOI: 10.1159/000108647     Document Type: Short Survey

References (30)

1. Sarnak MJ, Levey AS, Schoolwerth AC, Coresh J, Culleton B, Hamm LL, McCullough PA, Kasiske BL, et al: Kidney disease as a risk factor for development of cardiovascular disease. Circulation 2003;108:2154-2169.
2. Giannitsis E, Katus HA: Comparison of cardiac troponin T and troponin I assays - implications of analytical and biochemical differences on clinical performance. Clin Lab 2004;50:521-528.
3. Van Lente F, McErlean ES, DeLuca SA, Peacock WF, Rao JS, Nissen SE: Ability of troponins to predict adverse outcomes in patients with renal insufficiency and suspected acute coronary syndromes: a case-matched study. J Am Coll Cardiol 1999;33:471-478.
4. Apple FS, Murakami MM, Pearce LA, Herzog CA: Multi-biomarker risk stratification of N-terminal pro-B-type natriuretic peptide, high-sensitivity C-reactive protein, and cardiac troponin T and I in end-stage renal disease for all-cause death. Clin Chem 2004;50:2279-2285.
5. Iliou MC, Fumeron C, Benoit MO, Tuppin P, Courvoisier CL, Calonge VM, et al: Factors associated with increased serum levels of cardiac troponins T and I in chronic haemodialysis patients: Chronic Haemodialysis and New Cardiac Markers Evaluation (CHANCE) study. Nephrol Dial Transplant 2001;16:1452-1458.
6. deFilippi C, Wasserman S, Rosanio S, Tiblier E, Sperger H, Tocchi M, et al: Cardiac troponin T and C-reactive protein for predicting prognosis, coronary atherosclerosis, and cardiomyopathy in patients undergoing long-term hemodialysis. JAMA 2003;290:353-359.
7. Hocher B, Ziebig R, Altermann C, Krause R, Asmus G, Richter CM, et al: Different impact of biomarkers as mortality predictors among diabetic and nondiabetic patients undergoing hemodialysis. J Am Soc Nephrol 2003;14:2329-2337.
8. Havekes B, van Manen JG, Krediet RT, Boeschoten EW, Vandenbroucke JP, Dekker FW, NECOSAD Study Group: Serum troponin T concentration as a predictor of mortality in hemodialysis and peritoneal dialysis patients. Am J Kidney Dis 2006;47:823-829.
9. Sommerer C, Beimler J, Schwenger V, Heckele N, Katus HA, Giannitsis E, Zeier M: Cardiac biomarkers and survival in haemodialysis patients. Eur J Clin Invest 2007;37:350-356.
10. Mallamaci F, Zoccali C, Parlongo S, Tripepi G, Benedetto FA, Cutrupi S, et al: Troponin is related to left ventricular mass and predicts all-cause and cardiovascular mortality in hemodialysis patients. Am J Kidney Dis 2002;40:68-75.
11. Löwbeer C, Stenvinkel P, Pecoits-Filho R, et al: Elevated cardiac troponin T in predialysis patients is associated with inflammation and predicts mortality. J Intern Med 2003;253:153-160.
12. Diris JH, Hackeng CM, Kooman JP, Pinto YM, Hermens WT, van Dieijen-Visser MP: Impaired renal clearance explains elevated troponin T fragments in hemodialysis patients. Circulation 2004;109:23-25.
13. Lee JA, Kim DH, Yoo SJ, Oh DJ, Yu SH, Kang ET: Association between serum N-terminal pro-brain natriuretic peptide concentration and left ventricular dysfunction and extracellular water in continuous ambulatory peritoneal dialysis patients. Perit Dial Int 2006;26:360-365.
14. Khan IA, Fink J, Nass C, Chen H, Christenson R, deFilippi CR: N-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide for identifying coronary artery disease and left ventricular hypertrophy in ambulatory chronic kidney disease patients. Am J Cardiol 2006;97:1530-1534.
15. Wahl HG, Graf S, Renz H, Fassbinder W: Elimination of the cardiac natriuretic peptides B-type natriuretic peptide (BNP) and N-terminal proBNP by hemodialysis. Clin Chem 2004;50:1071-1074.
16. Costello-Boerrigter LC, Boerrigter G, Redfield MM, Rodehoffer RJ, Urban LH, Mahoney DW, et al: Amino-terminal pro-Btype natriuretic peptide and B-type natriuretic peptide in the general community: determinants and detection of left ventricular dysfunction. J Am Coll Cardiol 2006;47:345-353.
17. Goetze JP, Jensen G, Moller S, Bendtsen R, Rehfeld JF, Henriksen JH: BNP and N-terminal proBNP are both extracted in the normal kidney. Eur J Clin Invest 2006;36:8-15.
18. Boscato LM, Stuart MC: Heterophilic antibodies: a problem for all immunoassays. Clin Chem 1988;34:27-33.
19. Wang AY, Lam CW, Yu C, Wang M, Chan IH, Lui S, et al: Troponin T, left ventricular mass, and function are excellent predictors of cardiovascular congestion in peritoneal dialysis. Kidney Int 2006;70:444-452.
20. Törnig J, Amann K, Ritz E, Nichols C, Zeier M, Mall G: Arteriolar wall thickening, capillary rarefaction and interstitial fibrosis in the heart of rats with renal failure: the effects of ramipril, nifedipine and moxonidine. J Am Soc Nephrol 1996;7:667-675.
21. Ashikaga H, Covell JW, Omens JH: Diastolic dysfunction in volume overload hypertrophy is associated with abnormal shearing of myolaminar sheets. Am J Heart Circ Physiol 2005;288:2603-2610.
22. Wayand D, Baum H, Schätzle G, Schärf J, Neumeier D: Cardiac troponin T and I in end-stage renal failure. Clin Chem 2000;46:1345-1350.
23. Roberts MA, MacMillan N, Hare DL, Ratnaike S, Sikaris K, Fraenke M, Ierino FL: Cardiac troponin levels in asymptomatic patients on the renal transplant waiting list. Nephrology 2006;11:471-476.
24. Haller C, Katus HA: Expression of cardiac troponin T in skeletal muscle. Clin Chem 1998;44:358-359.
25. Dierkes J, Domrose U, Westphal S, Ambrosch A, Bosselmann HP, Neumann KH, Luley C: Cardiac troponin T predicts mortality in patients with end-stage renal disease. Circulation 2000;102:1964-1969.
26. Ooi DS, House AA: Cardiac troponin T in hemodialyzed patients. Clin Chem 1998;44:1410-1416.
27. Sharma R, Gaze DC, Pellerin D, Mehta RL, Gregson H, Streather CP, Collinson PO, Brecker SJ: Raised plasma N-terminal pro-Btype natriuretic peptide concentrations predict mortality and cardiac disease in endstage renal disease. Heart 2006;92:1518-1519.
28. Bibbins-Domingo K, Gupta R, Na B, Wu AH, Schiller NB, Whooly MA: N-terminal fragment of the prohormone brain-type natriuretic peptide (NT-proBNP), cardiovascular events, and mortality in patients with stable coronary heart disease. JAMA 2007;297:169-276.
29. Heeschen C, Hamm CW, Mitrovic V, Lantelme NH, White HD, Platelet Receptor Inhibition in Ischemic Syndrome Management (PRISM) Investigators: N-terminal pro-Btype natriuretic peptide levels for dynamic risk stratification of patients with acute coronary syndromes. Circulation 2004;110:3206-3212.
30. Austin WJ, Bhalla V, Hernandez-Arce I, Isakson SR, Beede J, Clopton P, Maisel AS, Fitzgerald RL: Correlation and prognostic utility of B-type natriuretic peptide and its amino-terminal fragment in patients with chronic kidney disease. Am J Clin Pathol 2006;126:506-512.